Literature DB >> 22732838

Race and the molecular origins of breast cancer in Chinese women: breast cancer in Chinese women.

Margaret Chen1, Ruliang Xu, James W Turner, Michael Warhol, Phyllis August, Peng Lee.   

Abstract

Although there is considerable controversy regarding the role of race in the etiology of human disease, evidence suggests that breast cancers are racially distinct diseases. Clinical features and genetic alterations are different in Chinese women with breast cancer compared with white women. These differences are significant and may influence clinical care. In this review, we summarize the literature addressing genetic heterogeneity in Chinese women with breast cancer. Data support important variations in genes involved in tumorigenic pathways of DNA repair, steroid synthesis and receptor expression, apoptosis, immunity, inflammation, cell cycle control, cancer growth and metastasis, and growth receptor signaling. These genetic differences contribute to our understanding of the molecular origins of breast cancer and may accelerate the development of personalized disease prevention strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22732838     DOI: 10.1245/s10434-012-2452-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

Review 1.  Jadomycins: A potential chemotherapy for multi-drug resistant metastatic breast cancer.

Authors:  Esther P Bonitto; Brendan T McKeown; Kerry B Goralski
Journal:  Pharmacol Res Perspect       Date:  2021-12

2.  Molecular breast cancer subtypes and therapies in a public hospital of northeastern Brazil.

Authors:  Ana Cláudia de Macêdo Andrade; Carlos Alberis Ferreira Júnior; Beatriz Dantas Guimarães; Ana Waleska Pessoa Barros; Gibran Sarmento de Almeida; Mathias Weller
Journal:  BMC Womens Health       Date:  2014-09-12       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.